Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 180 citing Flyvbjerg: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizin.... (0.09 sec) 

From the periphery of the glomerular capillary wall toward the center of disease

- diabetesjournals.org
G Wolf, S Chen, FN Ziyadeh - Diabetes, 2005 - Am Diabetes Assoc
Nephropathy is a major complication of diabetes. Alterations of mesangial cells have traditionally
been the focus of research in deciphering molecular mechanisms of diabetic nephropathy. Injury of
podocytes, if recognized at all, ...
Cited by 188 - Related articles - All 9 versions

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology


BF Schrijvers, A Flyvbjerg, AS De Vriese - Kidney international, 2004 - nature.com
Received 24 April 2003; Revised 7 August 2003; Re-revised 25 September 2003; Accepted 3 December
2003. ... The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Vascular
endothelial growth factor (VEGF) is ...
Cited by 145 - Related articles - BL Direct - All 7 versions

Microvascular basement membranes in diabetes mellitus


EC Tsilibary - The Journal of Pathology, 2003 - ingentaconnect.com
The alterations in the microvascular system of diabetes mellitus patients are responsible for the
most devastating complications of this widespread disease. In the kidney, the microan- giopathy
leads to thickening of the ...
Cited by 129 - Related articles - BL Direct - All 7 versions

From hyperglycemia to diabetic kidney disease: the role of metabolic, …

- endojournals.org
BF Schrijvers, AS De Vriese, A Flyvbjerg - Endocrine reviews, 2004 - Endocrine Soc
At present, diabetic kidney disease affects about 15–25% of type 1 and 30–40% of type 2 diabetic
patients. Several decades of extensive research has elucidated various pathways to be implicated in
the development of diabetic kidney ...
Cited by 122 - Related articles - All 5 versions

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in …

- diabetesjournals.org
Y Yamamoto, Y Maeshima, H Kitayama, S Kitamura, Y … - Diabetes, 2004 - Am Diabetes Assoc
In the early stage of diabetic nephropathy (one of the major microvascular complications of
diabetes) glomerular hyperfiltration and hypertrophy are observed. It is clinically important to
regulate glomerular hypertrophy for ...
Cited by 84 - Related articles - BL Direct - All 6 versions

Phenotypic heterogeneity of the endothelium: II. Representative vascular beds

- ahajournals.org
WC Aird - Circulation research, 2007 - Am Heart Assoc
Endothelial cells, which form the inner cellular lining of blood vessels and lymphatics, display
remarkable heterogeneity in structure and function. This is the second of a 2-part review on the
phenotypic heterogeneity of blood ...
Cited by 82 - Related articles - All 12 versions

Association of the VEGF gene with proliferative diabetic retinopathy but not …

- diabetesjournals.org
D Ray, M Mishra, S Ralph, I Read, R Davies, P … - Diabetes, 2004 - Am Diabetes Assoc
Diabetic retinopathy and nephropathy cause significant morbidity in patients with diabetes. Vascular
endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor and is
implicated in both of these ...
Cited by 81 - Related articles - BL Direct - All 5 versions

Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and …


P Dasgupta - Pharmacology and Therapeutics, 2004 - Elsevier
Angiogenesis, the development of new blood vessels is a crucial process both for tumor growth and
metastatic dissemination. Additionally, dysregulation in angiogenesis has been implicated in the
pathogenesis of cardiovascular ...
Cited by 78 - Related articles - All 4 versions

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic …


A Flyvbjerg, L Denner, BF Schrijvers, RG Tilton, TH … - Diabetes, 2004 - Am Diabetes Assoc
Advanced glycation end products (AGEs) have been implicated in the pathogenesis of diabetic kidney
disease. The actions of AGEs are mediated both through a non–receptor-mediated pathway and through
specific receptors for AGE (RAGEs). ...
Cited by 68 - Related articles - BL Direct - All 4 versions

Diabetes and nephropathy


ML Caramori, M Mauer - Current opinion in nephrology and …, 2003 - journals.lww.com
Recent findings: There have been advances in the understanding of diabetic nephropathy pathology.
Clearly, structural changes may be advanced before any clinical findings are apparent. Not all
functional consequences of the ...
Cited by 68 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google